Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
6
February
2020
Publication date Collection: 2020
Volume: 15
Issue: 2
Electronic Location Identifier: e0228544
Affiliations
[1
]
Firestone Institute for Respiratory Health, St Joseph’s Healthcare, Hamilton, Canada
[2
]
University of Manchester, Division of Infection, Immunity and Respiratory Medicine,
Manchester Academic Health Science Centre, Manchester, United Kingdom
[3
]
McMaster University Department of Medicine, Hamilton, Canada
National Yang-Ming University, TAIWAN
Author notes
Competing Interests: IS reports grant from the ERS RESPIRE3 Marie Curie Award, BMA James Trust Award, North
West Lung Centre Grant, personal fees from Merck MSD, AstraZenca, GSK, sponsorship
to attend conference meetings, outside the submitted work; RC, JMG, KJK, NJ have no
disclosures. PMO reports personal fees from oversight committee for LABA safety study,
consulting fees from AstraZeneca, GSK, Merck, Boehringer, grants from AstraZeneca,
Genentech, outside the submitted work. The research reported in this article was funded
by an unrestricted grant from AstraZeneca Canada to PMO with no input in data collection,
analysis, interpretation or writing of the manuscript. This does not alter our adherence
to PLOS ONE policies on sharing data and materials.
Author information
Article
Publisher ID:
PONE-D-19-31523
DOI: 10.1371/journal.pone.0228544
PMC ID: 7004370
PubMed ID: 32027687
SO-VID: cb91b174-7208-4221-880d-cf90127a5e63
Copyright © © 2020 Satia et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by: funder-id http://dx.doi.org/10.13039/100008207, AstraZeneca Canada;
Award ID: Unrestricted Grant
Award Recipient
:
Paul M. O’Byrne
The research reported in this article was funded by an unrestricted grant from AstraZeneca
Canada to PMO. The funder had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Pulmonology
Subject:
Asthma
Subject:
Medicine and Health Sciences
Subject:
Pulmonology
Subject:
Chronic Obstructive Pulmonary Disease
Subject:
Medicine and Health Sciences
Subject:
Critical Care and Emergency Medicine
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Medical microbiology
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Medicine and health sciences
Subject:
Pathology and laboratory medicine
Subject:
Pathogens
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Medicine and Health Sciences
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Influenza
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Coronaviruses
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Coronaviruses
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Coronaviruses
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral Pathogens
Subject:
Coronaviruses
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
DNA viruses
Subject:
Parvoviruses
Subject:
Adeno-Associated Viruses
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Parvoviruses
Subject:
Adeno-Associated Viruses
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Parvoviruses
Subject:
Adeno-Associated Viruses
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral Pathogens
Subject:
Parvoviruses
Subject:
Adeno-Associated Viruses
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza B virus
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Medical microbiology
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza B virus
Subject:
Medicine and health sciences
Subject:
Pathology and laboratory medicine
Subject:
Pathogens
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza B virus
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza B virus
